Join
Live feed
·
INSIDERFilingvia Quantisnow
Prevail Therapeutics Inc. logo

SEC Form 4: Corp Acquisition Tyto bought $771,407,752 worth of Common Stock (34,284,789 units at $22.50)

ByQuantisnow·Wall Street's wire, on your screen.
PRVL· Prevail Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PRVL (Prevail Therapeutics Inc.) and more on Quantisnow.